In METABRIC, HER2+ tumors had the highest proportion in BC-ImH and the lowest proportion in BC-ImL (BC-ImH (20.6%) versus BC-ImM (12.4%) versus BC-ImL (7.7%)) (p < 0.001) (Figure 3C). The gene discussed is ERBB2; the disease is breast cancer.